stockrowAurinia Pharmaceuticals Inc (AUPH) vs Lakefront Biotherapeutics - Sponsored ADR (LKFT)
- Aurinia Pharmaceuticals Inc AUPH 16.30 +0.56%
- Lakefront Biotherapeutics - Sponsored ADR LKFT 33.27 −0.86%
Aurinia Pharmaceuticals Inc and Lakefront Biotherapeutics - Sponsored ADR are both Biotechnology companies. Aurinia Pharmaceuticals Inc and Lakefront Biotherapeutics - Sponsored ADR are of similar size ($2.2B and $2.2B). Lakefront Biotherapeutics - Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Aurinia Pharmaceuticals Inc trades at 6.8×. Aurinia Pharmaceuticals Inc grew revenue faster over the last twelve months: 21.0% against −52.2%. Aurinia Pharmaceuticals Inc has the higher net margin (97.7% vs −6.81%) and the higher return on invested capital (43.0% vs 0.00%). Across the 19 metrics below, Aurinia Pharmaceuticals Inc leads on 13 and Lakefront Biotherapeutics - Sponsored ADR on 6.
Valuation
Profitability
| Metric | AUPH | LKFT | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.62% | 89.75% | 65.16% |
| Operating margin | 44.78% | (90.11%) | 0.00% |
| Net margin | 97.68% | (6.81%) | 0.00% |
| Free cash flow margin | 55.02% | 0.00% | 0.00% |
| Return on equity | 61.42% | 0.00% | (50.12%) |
| Return on assets | 46.45% | 0.00% | (45.60%) |
| Return on invested capital | 42.95% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack